B · Normal
[Dizhe Pharmaceuticals: Resubmit application for H-share issuance and listing to the Hong Kong Stock Exchange] On August 28, Dizhe Medicine announced in the morning that the company resubmitted its application to the Hong Kong Stock Exchange for issuance of H shares and listing on the main board of the Hong Kong Stock Exchange on August 27, and published the application materials for this issuance and listing on the Hong Kong Stock Exchange website on the same day.
A股公告速递 🕐 2026-08-28 08:19
#motherboard #A-share announcement express #medicine
← Telegraph

Related telegraphs

【深圳前海：鼓励面向低空经济企业开展上市培育、合规辅导及跨境资本服务】8月28日电，据“深圳发布”微信公众号消息，《前海深港现代服务业合作区金融赋能低空经济产业 08-28 14:19 【恩华药业：获得布瑞哌唑片药品注册证书】8月28日电，恩华药业午间公告，公司于近日获得国家药监局核准签发的化学药品布瑞哌唑片的《药品注册证书》，布瑞哌唑片用于治 08-28 11:46 [Shenghong Technology: Adjustment of the internal equity structure of the contro 08-28 08:18 [Liu Xin, the fourth largest shareholder of Guosheng Technology, reduced his pos 08-27 22:25 [Guosheng Technology: Net loss in the first half of the year was 86.3456 million 08-27 22:24 [ST Xinhuajin: Its controlled subsidiary Shanghai Lizhi will no longer be includ 08-27 22:20

Comments

0/500
验证码
No comments yet